You are here

P&T News

October 19

Updated data show median overall survival of 30.0 months
Treatment targets relapsed or refractory large B-cell lymphoma
Insurer enlists CVS Health to help in replacing Express Scripts
Announcement follows judge’s ruling to toss patents
Alternative offers better pain relief, could help curb opioid epidemic

October 17

Reports indicate he worked to weaken federal efforts to restrict opioids
Figures are even higher for minorities and women
Sophisticated management of life-threatening complications could double cost of care

October 16

ALK-positive and ROS1-positive patients benefit
Application to FDA expected in early 2018
Senhance System aids surgeons in minimally invasive procedures
New indication follows study showing significant skin clearance at week 12

October 12

“Moonshot” goal: Spread success to patients in half the time
Siemens Magnetom Terra doubles available magnetic field strength

October 10

Investigational peptide vaccine induces attack on various cancers
Company considering sale or spin-off of multibillion-dollar OTC business
When patients wrongly report drug allergies, doctors use inferior drugs, study finds
While restrictions are increasing, a third of plans impose none
“Unfortunate” outcome in phase 3 JUNIPER trial of abemaciclib

Pages